Endosteal Implants Market

The market for Endosteal Implants was estimated at $3.7 billion in 2025; it is anticipated to increase to $5.3 billion by 2030, with projections indicating growth to around $7.6 billion by 2035.

Report ID:DS1801135

Author:Debadatta Patel - Senior Consultant

Published Date:February 2025

Datatree

Life Science

Medical Device

Endosteal Implants

Customization Available

Endosteal Implants - 2025-2035

Market Outlook
Market Key Insights
Growth Opportunity
Market Dynamics
Application
Recent Development
Impact Analysis

Report Summary

Market Data

Methodology

Table of Contents

Report Summary

Market Data

Methodology

Table of Contents

Global Endosteal Implants Market Outlook

Revenue, 2025

$3.7B

Forecast, 2035

$7.6B

CAGR, 2026 - 2035

7.4%

The Endosteal Implants industry revenue is expected to be around $3.7 billion in 2026 and expected to showcase growth with 7.4% CAGR between 2026 and 2035. The dental implants industry, with its endosteal implants segment, is an region of significant growth due to the increased incidence of tooth loss and the patients preference for fixed dental restorations over removable dentures. As clinicians are increasingly aware of the long term benefits and the integration of implants into the bone, it is likely that they will prefer endosteal implants to restore aesthetic and functional oral health. The tapered implants product was the leading revenue source for the endosteal implants industry, with sales of approximately $2.78 billion in 2025. This strong revenue reflects the clinicians confidence in the products primary stability and its effectiveness for patients with challenging bone conditions. The market was dominated by a high degree of customer focus, with dental clinics and DSOs accounting for 85.1% of demand in the market. This dominance by dental clinics and DSOs was because of the concentration of purchasing power, standardisation of dental treatments and the integration of dental implants into dental care.

These endosteal dental implants are anchored straight into the jawbone via surgical operation, they normally come in a tapered or screw shaped form and these are usually made from a strong, non reactive material. They support the construction of durable artificial restorations which look like natural teeth. These features include excellent integration with the surrounding bone, the ability to bear heavy loads, and compatibility with a range of dental implants and prosthetic devices. This makes them suitable for one tooth replacements, multiple dental bridges and full sets of teeth. Everyday restorative dentistry together with the immediate or early loading protocols and comprehensive oral rehabilitation are the main applications of this dental implant material. In many cases these are used along with other dental procedures such as bone grafting. Bone grafting increases the quality of the site for the dental implants. The growing demand for endosteal implants is largely attributed to several key trends. One of these factors is the increased use of tapered implant designs which provide improved primary stability. A second trend is the growth in the use of guided and minimally invasive surgical techniques. Additionally, a trend in the industry towards the integration of digital diagnostic and CAM/CAD technology is also in place. This convergence of factors enables endosteal implants to offer precision and reduced chair times, which is seen as an advantage by modern dental surgeons.

Endosteal Implants market outlook with forecast trends, drivers, opportunities, supply chain, and competition 2025-2035 — Endosteal Implants Market Outlook

Market Key Insights

The Endosteal Implants market is projected to grow from $3.7 billion in 2025 to $7.6 billion in 2035. This represents a CAGR of 7.4%, reflecting rising demand across Dental Restoration, Orthopedic Surgery, and Maxillofacial Surgery.
Market leaders such as Dentsply Sirona, Envista Holdings Corporation, and Straumann influence market dynamics.
The U. S and Germany are expected to have the largest market share for endosteal implants. They will grow at 4.8 to 7.1% CAGR from 2025 to 2030.
The countries likely to experience the greatest growth are those in the emerging markets, specifically India, Brazil and South Korea with their compound annual growth rate ranging from 8.5% to 10.2% .
By 2030, the advancements expected in technology could increase the endosteal implants market size by $432 million.
Over the next ten years the endosteal implants industry will grow by $3.9 billion. It is anticipated that dental clinics and group practices owned by a single entity will dominate the dental clinics and group practices owned by a single entity application.
Due to the increase in the incidence of oral health issues, the endosteal dental implants market is predicted to grow by 104% between 2035 and 2025.

Endosteal Implants - Country Share Analysis

Opportunities in the Endosteal Implants

Rapid expansion in private implantology clinics in India and South East Asia is also producing high volume opportunities for endosteal implants at low cost. Investing in digital dentistry, cone beam computed tomography and three dimensional printed surgical guides, clinics are able to standardise the outcome of their treatments and reduce chair side time. This region is expected to be the greatest for immediate loading in dense anterior bone and multi unit bridges, with walled implants that are parallel globally projected to increase from $0.96 billion in 2025 to $1.29 billion in 2030 at 6.20% CAGR.

Growth Opportunities in North America and Asia Pacific

The adoption rate for endosteal implants in North America is primarily driven by high expectations regarding aesthetics, the widespread presence of insurance coverage for dentistry involving implants, and the swift adoption of digital dentistry and 3D guided surgery techniques. Dental Service Organisations are becoming key end users due to their purchasing power, clinical protocols and focus on dental implants which can be easily scaled. The top opportunities include a partnership with large DSOs for the sale of value tier and premium titanium dental implants. Another region of opportunity is the development of streamlined surgical kits and prosthetic components which are optimised for high volume implant procedures. Additionally, investment in clinical education platforms could also be considered. These platforms reduce chair time and improve the osseointegration of implants. In the highly competitive dental markets, there is a combination of established, premium dental brands and mid priced challengers trying to gain ground. Additionally, private label products are included in DSO supply chains. Consequently, an opportunity arises for a differentiated positioning based on long term clinical research, digital workflow integration and total oral rehabilitation solutions. Prioritization of strategic focus should centre on DSO centric contracting models, dental implant surgery training programmes run in hospitals for complex work and data driven services sold to independent dental clinics who wish to compete with large corporate entities.

The region of Asia Pacific is witnessing a growth in the use of endosteal implants thanks to a growing middle class. Other factors contributing to this growth are a rise in private dental clinics, the growth of dental tourism and increasing awareness of the benefits of implant dentistry. Clinics that deal privately with patients are driving demand in this region. Hospitals in this region also handle the complex bone grafting and full mouth reconstruction operations. Companies may achieve the greatest success by offering tiered ranges of dental implants. These ranges could be balanced so that they offer both good reliability and affordable prices. Training should be offered to dentists in specific locations so that they can gain the skills necessary to carry out dental implant operations. Dental implant products are manufactured to meet the needs of different countries. This means the products are suited to the particular bone composition and the level of dental care available in each country. The dental equipment industry has multiple companies competing with one another, with local manufacturers and budget brands from the same country, plus multinational corporations. This is resulting in a high level of price competition which has accelerated the development of basic dental procedures and digital dental tools. Business strategies should consider local manufacturing, forming partnerships with dentists in cities and key hospital doctors who can influence others in their field to raise the companys reputation. Investment in customer support and providing information to dentists on how to use products will also help to attract and keep customers in urban centres and smaller towns.

Market Dynamics and Supply Chain

Driver: Rising Prevalence of Tooth Loss Combined with Growing Demand for Minimally Invasive, Digitally‑Guided Implant Solutions

A key driver for the endosteal implants market is also the increasing prevalence of tooth loss globally coupled with the rising demand for minimally invasive and digitally‑guided implant procedures. Aging populations, higher incidences of periodontal disease, and trauma‑related tooth loss have also expanded the pool of patients seeking durable dental restorations. Endosteal implants, particularly titanium screw‑type systems, offer predictable osseointegration, long‑term stability, and functional restoration of masticatory capacity, making them the preferred choice in general and specialist dental practices. Separately, advancements in digital dentistry technologies such as cone beam CT imaging, CAD/CAM surgical guides, and computer‑assisted implant planning are also transforming clinical workflows. These innovations reduce surgical time, improve placement precision, and enhance patient comfort and outcomes. As clinicians adopt guided surgery protocols, patient acceptance increases, reinforcing demand for endosteal implants that integrate with digital tools. Together, rising edentulism and digital integration drive market growth, prompting manufacturers like Straumann Group, Nobel Biocare, and Dentsply Sirona to invest in smart surgical systems and comprehensive training programs, strengthening their competitive positions in the dental implant ecosystem.

Another primary driver of the endosteal implants market is also the advancement of biomaterials and surface modification technologies. Innovations in titanium alloys, zirconia implants, and nanostructured surface treatments improve bone‑to‑implant contact and accelerate osseointegration, leading to higher success rates and faster recovery. These enhancements reduce peri‑implant complications and support use in diverse clinical scenarios such as immediate loading and compromised bone conditions. Manufacturers focusing on enhanced implant surfaces and bioactive coatings gain a strategic edge as clinicians favor materials that deliver consistent clinical outcomes.

Restraint: High Costs and Limited Reimbursement Coverage

Endosteal implants are often considered a treatment choice that may be unaffordable for numerous individuals seeking such care options due to their steep prices and the expenses linked to the necessary surgical procedures for their installation which limits market expansion despite their rising popularity. Due to public health coverage for endosteal implants by insurance providers such financial constraints are further compounded, resulting in added monetary stress, for patients.

Opportunity: Premium Endosteal Implants for Cosmetic-Focused Urban Professionals in Western Europe and Rising demand for Endosteal Implants among aging edentulous adults in United States dental clinics

There is a growing trend in Western Europe for dental surgeons to see endosteal implants as high end cosmetic treatments, rather than purely practical ones. This has generated a demand for implants that are not only made of metal and which are gentle on the gum. The preferred solution in this case is a tapered implant with a reduced diameter at the base. Moreover, an advanced zirconia implant material is used which helps to keep the gums in the maxilla region aesthetically pleasing and the underlying bone healthy. These dental clinics offering same day restoration techniques along with their in house milling services can charge higher fees. Furthermore, they differentiate themselves from those clinics that offer cheaper dental services. As a result, aesthetic single tooth replacements and short bridges involving a few teeth are growing rapidly in Europe's established dental implant markets.

In the United States, there is a rising trend in the adoption of endosteal implants; this is mainly due to the desire of the ageing baby boomer generation for secure denture alternatives and their preference for full dentures supported by implants and provided through general dental practitioners as opposed to specialists. The market for tapered implants, expected to rise to $4.05 billion in the year 2030 from a projected 2.78 billion in 2025, will continue at a rate of 7.8% compound annual growth. Tapered implants will likely take a significant portion of this market as they offer greater primary stability in conditions of poor bone quality. By offering treatment bundles and financing options to dentists in practice, vendors can free up more time in the dental chair.

Challenge: Technological Challenges and Regulatory Compliance

In the realm of Endosteal implants market advancement remains crucial with the emergence of technologies. However the growth of this market faces obstacles due to frequent product recalls triggered by defects and non adherence to regulatory standards. Manufacturers are required to adhere to criteria for market acceptance making the procedure of developing, testings and introducing endosteal implants arduous and time consuming. This strict regulatory framework might discourage newcomers from joining the market scenario resulting in a hindrance, to its overall expansion.

Supply Chain Landscape

Implant Materials

Dentsply SironaZimVie Inc

Endosteal Implants Manufacturing

Institut Straumann AGEnvista Holdings Corporation

Dental Distribution

Henry Schein Inc.Dentsply Sirona

Clinical Implantology

Dental clinicsHospitalsOral surgery centers

Implant Materials

Dentsply SironaZimVie Inc

Endosteal Implants Manufacturing

Institut Straumann AGEnvista Holdings Corporation

Dental Distribution

Henry Schein Inc.Dentsply Sirona

Clinical Implantology

Dental clinicsHospitalsOral surgery centers

Endosteal Implants - Supply Chain

Use Cases of Endosteal Implants in Dental Restoration & Orthopedic Surgery

Dental Restoration : Endosteal implants are the most common choice for dental restoration, consisting of titanium screw‑ or cylinder‑shaped implants placed directly into the jawbone to support crowns, bridges, or full arch prosthetics. Their design promotes strong osseointegration, offering high success and longevity in replacing missing teeth and restoring chewing function. Clinicians widely prefer screw‑type endosteal implants for their stability and predictability in dental clinics and hospitals. Leading providers such as Straumann Group, Nobel Biocare Services AG, Dentsply Sirona, Zimmer Biomet, and Osstem Implant Co., Ltd. dominate this space with advanced implant systems, digital planning tools, and broad clinical support networks. These companies enhance procedural efficiency through guided surgery technology and materials innovation, reinforcing their strong positions in restorative dentistry.

Orthopedic Surgery : While endosteal implants are primarily associated with dental applications, analogous intramedullary or bone fixation implants used in orthopedic surgery share similar principles of anchoring into bone to stabilize and support fractured or replaced bone segments. In orthopedic contexts, titanium and other biocompatible materials used in endosteal dental implants also underpin joint replacements and internal fixation devices. Major medical device firms such as Zimmer Biomet and Straumann Group (via broader Enovis portfolio) offer a range of titanium orthopedic systems with excellent biocompatibility and mechanical strength, contributing to improved patient outcomes in hip, knee, and long‑bone procedures.

Maxillofacial Surgery : In maxillofacial surgery, endosteal implants support reconstruction of facial bones, dental arches, and jaw continuity in trauma or congenital defect repair. Surgeons use titanium endosteal implants and bone plates to anchor bone segments and prosthetic components within the craniofacial skeleton, relying on the high strength and osseointegration capability of such implants. Providers like Zimmer Biomet, Osstem, and BioHorizons Implant Systems supply implant systems and fixation devices tailored for complex oral and maxillofacial reconstruction. Their robust product portfolios and global distribution ensure availability across specialized surgical centers, enhancing functional and aesthetic results for patients requiring reconstructive surgery.

Recent Developments

Recent developments in endosteal implants emphasize digital dentistry integration, guided implant surgery, and advanced surface technologies that improve osseointegration and clinical outcomes. A key trend is the adoption of CAD/CAM-assisted implant planning and 3D imaging, enabling more precise placement and faster recovery. Manufacturers are expanding implant system portfolios with bioactive surfaces and customizable prosthetic interfaces to meet growing demand in dental restoration and reconstructive surgery, reinforcing market growth and improving patient satisfaction.

September 2024 : Nobel Biocare officially announced the Nobel Pearl Max, a ceramic endosteal implant system, supported by company communications and coverage in dental trade publications. This launch is well documented and aligns with Nobel Biocare’s zirconia implant strategy.

March 2023 : Dentsply Sirona publicly launched the DS OmniTaper Implant System at the Academy of Osseointegration meeting. This is supported by company press releases and professional dental conference documentation.

Impact of Industry Transitions on the Endosteal Implants Market

As a core segment of the Medical Device industry, the Endosteal Implants market develops in line with broader industry shifts. Over recent years, transitions such as Technological Advancement and Increased Demand for Personalized Treatment have redefined priorities across the Medical Device sector, influencing how the Endosteal Implants market evolves in terms of demand, applications and competitive dynamics. These transitions highlight the structural changes shaping long-term growth opportunities.

Technological Advancement

With developments in dental implants, including the use of CAD/CAM systems, digital imaging and newer, biocompatible materials, the dental implants industry is moving from the traditional placement method towards more customised implant placement. These improvements in the form of more accurate 3D imaging, the use of guided surgery and better design of prosthetics result in better clinical results, less time spent in waiting rooms and greater patient satisfaction, thus they have encouraged more doctors to use them. This transition is one of significant and not only merely incremental progress; technological progress is likely to add another $432 million to the sales of endosteal implants by 2030. This underlines the importance of ongoing investment in the digitalisation of dental procedures and in advanced materials science in order to maintain a premium price for these products and to stay ahead of competitors in the dental implant market.

Increased Demand for Personalized Treatment

Personalised dental healthcare has made a significant impact on the field of endosteal implants in recent years. Due to rapid developments in 3D printing technology as well as the expanding precision medicine sector, surgeons are now requiring endosteal implants more frequently. Customised endosteal implants designed with a patients unique anatomical and clinical requirements in mind have introduced a significant innovation into dental implant technology. While minimally invasive treatments have been found to provide both enhanced patient comfort and improved clinical outcomes, they also boost patient satisfaction.